I.M. Chelnokova
Research Subjects
I.M. Chelnokova has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aleksei V. Mostovoi
Vorokhobov City Clinical Hospital № 67, Moscow Healthcare Department; Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation; Yaroslavl State Medical University, Ministry of Health of the Russian Federation
1 shared publication - Anna L. Karpova
Vorokhobov City Clinical Hospital № 67, Moscow Healthcare Department; Russian Medical Academy of Continuous Professional Education, Ministry of Health of the Russian Federation; Yaroslavl State Medical University, Ministry of Health of the Russian Federation
1 shared publication Kaluga Kaluga Oblast Regional Clinical Hospital
1 shared publication- M.A. Kovaleva1 shared publication
- N. Yu. Karpov
Tutaev Central District Hospital
1 shared publication - S.Yu. Kirdyanov1 shared publication
Latest Publications
- 18 February 2022
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 101 (1)
CONGENITAL INFECTION CAUSED BY THE SARS-CоV-2: LITERATURE REVIEW AND FIRST CLINICAL CASE
COVID-19 is a disease caused by the novel SARS-CoV-2, is a severe systemic thrombotic syndrome with respiratory tract damage that emerged in 2019 in China with the development of a subsequent pandemic. Over the past two years, very little information has been accumulated on the prevalence, transmission routes, and the clinical picture of the disease among newborn infants. Given the limited data in the domestic literature, authors present not only a description of the first clinical observation of confirmed new coronavirus infection in a premature newborn, but also a brief review of the literature on the description of the epidemiology, clinic and methods of therapy for COVID-19 in infants.
- 18 February 2022
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 101 (1)
CONGENITAL INFECTION CAUSED BY THE SARS-CоV-2: LITERATURE REVIEW AND FIRST CLINICAL CASE
COVID-19 is a disease caused by the novel SARS-CoV-2, is a severe systemic thrombotic syndrome with respiratory tract damage that emerged in 2019 in China with the development of a subsequent pandemic. Over the past two years, very little information has been accumulated on the prevalence, transmission routes, and the clinical picture of the disease among newborn infants. Given the limited data in the domestic literature, authors present not only a description of the first clinical observation of confirmed new coronavirus infection in a premature newborn, but also a brief review of the literature on the description of the epidemiology, clinic and methods of therapy for COVID-19 in infants.